{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:39:00Z","timestamp":1787611140785,"version":"build-2736575974"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TR240 TP A03"],"award-info":[{"award-number":["TR240 TP A03"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002723","name":"Allianz Industrie Forschung","doi-asserted-by":"publisher","award":["TR225 TP B04"],"award-info":[{"award-number":["TR225 TP B04"]}],"id":[{"id":"10.13039\/501100002723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathological angiogenesis promotes tumor growth, metastasis, and atherosclerotic plaque rupture. Macrophages are key players in these processes. However, whether these macrophages differentiate from bone marrow-derived monocytes or from local vascular wall-resident stem and progenitor cells (VW-SCs) is an unresolved issue of angiogenesis. To answer this question, we analyzed vascular sprouting and alterations in aortic cell populations in mouse aortic ring assays (ARA). ARA culture leads to the generation of large numbers of macrophages, especially within the aortic adventitia. Using immunohistochemical fate-mapping and genetic in vivo-labeling approaches we show that 60% of these macrophages differentiate from bone marrow-independent Ly6c<jats:sup>+<\/jats:sup>\/Sca-1<jats:sup>+<\/jats:sup> adventitial progenitor cells. Analysis of the <jats:italic>NCX<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mouse model that genetically lacks embryonic circulation and yolk sac perfusion indicates that at least some of those progenitor cells arise yolk sac-independent. Macrophages represent the main source of VEGF in ARA that vice versa promotes the generation of additional macrophages thereby creating a pro-angiogenetic feedforward loop. Additionally, macrophage-derived VEGF activates CD34<jats:sup>+<\/jats:sup> progenitor cells within the adventitial vasculogenic zone to differentiate into CD31<jats:sup>+<\/jats:sup> endothelial cells. Consequently, depletion of macrophages and VEGFR2 antagonism drastically reduce vascular sprouting activity in ARA. In summary, we show that angiogenic activation induces differentiation of macrophages from bone marrow-derived as well as from bone marrow-independent VW-SCs. The latter ones are at least partially yolk sac-independent, too. Those VW-SC-derived macrophages critically contribute to angiogenesis, making them an attractive target to interfere with pathological angiogenesis in cancer and atherosclerosis as well as with regenerative angiogenesis in ischemic cardiovascular disorders.<\/jats:p>","DOI":"10.1038\/s41419-022-04605-2","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T18:03:00Z","timestamp":1646848980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bone marrow-independent adventitial macrophage progenitor cells contribute to angiogenesis"],"prefix":"10.1038","volume":"13","author":[{"given":"Florian","family":"Kleefeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berin","family":"Upcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"B\u00f6mmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8149-0747","authenticated-orcid":false,"given":"Christian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Eckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Allmanritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Braunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-4725","authenticated-orcid":false,"given":"Uwe","family":"Rueckschloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"4605_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10456-017-9541-1","volume":"20","author":"J Filipowska","year":"2017","unstructured":"Filipowska J, Tomaszewski KA, Nied\u017awiedzki \u0141, Walocha JA, Nied\u017awiedzki T. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis. 2017;20:291\u2013302.","journal-title":"Angiogenesis"},{"key":"4605_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932\u20136.","journal-title":"Nature"},{"key":"4605_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nature04482","volume":"438","author":"RF Gariano","year":"2005","unstructured":"Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438:960\u20136.","journal-title":"Nature"},{"key":"4605_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10456-016-9510-0","volume":"19","author":"S Subhani","year":"2016","unstructured":"Subhani S, Vavilala DT, Mukherji M. HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies. Angiogenesis. 2016;19:257\u201373.","journal-title":"Angiogenesis"},{"key":"4605_CR5","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1073\/pnas.0802857105","volume":"105","author":"S Wang","year":"2008","unstructured":"Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci USA. 2008;105:7738\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4605_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2:1097\u2013105.","journal-title":"Genes Cancer"},{"key":"4605_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69:4\u201310. Suppl 3","journal-title":"Oncology"},{"key":"4605_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc2403","volume":"8","author":"LM Ellis","year":"2008","unstructured":"Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008;8:579\u201391.","journal-title":"Nat Rev Cancer"},{"key":"4605_CR9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","volume":"100","author":"L Lamalice","year":"2007","unstructured":"Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res. 2007;100:782\u201394.","journal-title":"Circ Res"},{"key":"4605_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrm3176","volume":"12","author":"SP Herbert","year":"2011","unstructured":"Herbert SP, Stainier DYR. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011;12:551\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4605_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fphys.2013.00159","volume":"4","author":"JL Owen","year":"2013","unstructured":"Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis. Front Physiol. 2013;4:159.","journal-title":"Front Physiol"},{"key":"4605_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/micc.12259","volume":"23","author":"BA Corliss","year":"2016","unstructured":"Corliss BA, Azimi MS, Munson JM, Peirce SM, Murfee WL. Macrophages: an inflammatory link between angiogenesis and lymphangiogenesis. Microcirculation. 2016;23:95\u2013121.","journal-title":"Microcirculation"},{"key":"4605_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1189\/jlb.1105656","volume":"80","author":"C Lamagna","year":"2006","unstructured":"Lamagna C, Aurrand-Lions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol. 2006;80:705\u201313.","journal-title":"J Leukoc Biol"},{"key":"4605_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49\u201361.","journal-title":"Immunity"},{"key":"4605_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"4605_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0002-9440(10)65601-5","volume":"153","author":"M Xiong","year":"1998","unstructured":"Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages. Am J Pathol. 1998;153:587\u201398.","journal-title":"Am J Pathol"},{"key":"4605_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1242\/jcs.00286","volume":"116","author":"S Kiriakidis","year":"2003","unstructured":"Kiriakidis S, Andreakos E, Monaco C, Foxwell B, Feldmann M, Paleolog E. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J Cell Sci. 2003;116:665\u201374. Pt 4","journal-title":"J Cell Sci"},{"key":"4605_CR18","first-page":"4625","volume":"56","author":"RD Leek","year":"1996","unstructured":"Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996;56:4625\u20139.","journal-title":"Cancer Res"},{"key":"4605_CR19","doi-asserted-by":"publisher","first-page":"e0170042","DOI":"10.1371\/journal.pone.0170042","volume":"12","author":"S Yin","year":"2017","unstructured":"Yin S, Huang J, Li Z, Zhang J, Luo J, Lu C, et al. The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: a meta-analysis. PLoS ONE. 2017;12:e0170042.","journal-title":"PLoS ONE"},{"key":"4605_CR20","doi-asserted-by":"publisher","first-page":"e0125728","DOI":"10.1371\/journal.pone.0125728","volume":"10","author":"JM Gwak","year":"2015","unstructured":"Gwak JM, Jang MH, Kim DI, Seo AN, Park SY. Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer. PLoS ONE. 2015;10:e0125728.","journal-title":"PLoS ONE"},{"key":"4605_CR21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/ijc.24378","volume":"125","author":"H Fujimoto","year":"2009","unstructured":"Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M, et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer. 2009;125:1276\u201384.","journal-title":"Int J Cancer"},{"key":"4605_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48051-1","volume":"9","author":"N Volodko","year":"2019","unstructured":"Volodko N, Gutor T, Petronchak O, Huley R, D\u00facka M, \u0160marda J, et al. Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors. Sci Rep. 2019;9:11634.","journal-title":"Sci Rep."},{"key":"4605_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/neuonc\/nov245","volume":"18","author":"N Butowski","year":"2016","unstructured":"Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro Oncol. 2016;18:557\u201364.","journal-title":"Neuro Oncol"},{"key":"4605_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2018.00049","volume":"8","author":"AR Poh","year":"2018","unstructured":"Poh AR, Ernst M. Targeting macrophages in cancer: from bench to bedside. Front Oncol. 2018;8:49.","journal-title":"Front Oncol"},{"key":"4605_CR25","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.18632\/oncotarget.7376","volume":"7","author":"SY Lim","year":"2016","unstructured":"Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget. 2016;7:28697\u2013710.","journal-title":"Oncotarget"},{"key":"4605_CR26","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/1078-0432.CCR-13-2200","volume":"20","author":"E Angevin","year":"2014","unstructured":"Angevin E, Tabernero J, Elez E, Cohen SJ, Bahleda R, van Laethem J-L, et al. A phase I\/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res. 2014;20:2192\u2013204.","journal-title":"Clin Cancer Res"},{"key":"4605_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11523-014-0320-2","volume":"10","author":"I Brana","year":"2015","unstructured":"Brana I, Calles A, LoRusso PM, Yee LK, Puchalski TA, Seetharam S, et al. Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol. 2015;10:111\u201323.","journal-title":"Target Oncol"},{"key":"4605_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","volume":"31","author":"KJ Pienta","year":"2013","unstructured":"Pienta KJ, Machiels J-P, Schrijvers D, Alekseev B, Shkolnik M, Crabb SJ, et al. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest N Drugs. 2013;31:760\u20138.","journal-title":"Invest N Drugs"},{"key":"4605_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCRESAHA.115.303299","volume":"115","author":"PJ Psaltis","year":"2014","unstructured":"Psaltis PJ, Puranik AS, Spoon DB, Chue CD, Hoffman SJ, Witt TA, et al. Characterization of a resident population of adventitial macrophage progenitor cells in postnatal vasculature. Circ Res. 2014;115:364\u201375.","journal-title":"Circ Res"},{"key":"4605_CR30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.305368","volume":"116","author":"PJ Psaltis","year":"2015","unstructured":"Psaltis PJ, Simari RD. Vascular wall progenitor cells in health and disease. Circ Res. 2015;116:1392\u2013412.","journal-title":"Circ Res"},{"key":"4605_CR31","first-page":"681","volume":"25","author":"D Klein","year":"2010","unstructured":"Klein D, Hohn H-P, Kleff V, Tilki D, Erg\u00fcn S. Vascular wall-resident stem cells. Histol Histopathol. 2010;25:681\u20139.","journal-title":"Histol Histopathol"},{"key":"4605_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCRESAHA.117.312526","volume":"123","author":"SR Mekala","year":"2018","unstructured":"Mekala SR, W\u00f6rsd\u00f6rfer P, Bauer J, Stoll O, Wagner N, Reeh L, et al. Generation of cardiomyocytes from vascular adventitia-resident stem cells. Circ Res. 2018;123:686\u201399.","journal-title":"Circ Res"},{"key":"4605_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12015-008-9028-y","volume":"4","author":"S Erg\u00fcn","year":"2008","unstructured":"Erg\u00fcn S, Hohn H-P, Kilic N, Singer BB, Tilki D. Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells. Stem Cell Rev. 2008;4:169\u201377.","journal-title":"Stem Cell Rev"},{"key":"4605_CR34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1242\/dev.02315","volume":"133","author":"E Zengin","year":"2006","unstructured":"Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, Lauke H, et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006;133:1543\u201351.","journal-title":"Development"},{"key":"4605_CR35","doi-asserted-by":"publisher","first-page":"e20540","DOI":"10.1371\/journal.pone.0020540","volume":"6","author":"D Klein","year":"2011","unstructured":"Klein D, Weisshardt P, Kleff V, Jastrow H, Jakob HG, Erg\u00fcn S. Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS ONE. 2011;6:e20540.","journal-title":"PLoS ONE"},{"key":"4605_CR36","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1160\/TH07-04-0318","volume":"98","author":"S Erg\u00fcn","year":"2007","unstructured":"Erg\u00fcn S, Tilki D, Hohn H-P, Gehling U, Kilic N. Potential implications of vascular wall resident endothelial progenitor cells. Thromb Haemost. 2007;98:930\u20139.","journal-title":"Thromb Haemost"},{"key":"4605_CR37","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.4049\/jimmunol.181.8.5711","volume":"181","author":"M Gelati","year":"2008","unstructured":"Gelati M, Aplin AC, Fogel E, Smith KD, Nicosia RF. The angiogenic response of the aorta to injury and inflammatory cytokines requires macrophages. J Immunol. 2008;181:5711\u20139.","journal-title":"J Immunol"},{"key":"4605_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1152\/physiolgenomics.00048.2006","volume":"27","author":"AC Aplin","year":"2006","unstructured":"Aplin AC, Gelati M, Fogel E, Carnevale E, Nicosia RF. Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. Physiol Genomics. 2006;27:20\u20138.","journal-title":"Physiol Genomics"},{"key":"4605_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10456-013-9384-3","volume":"17","author":"AC Aplin","year":"2014","unstructured":"Aplin AC, Ligresti G, Fogel E, Zorzi P, Smith K, Nicosia RF. Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors. Angiogenesis. 2014;17:147\u201361.","journal-title":"Angiogenesis"},{"key":"4605_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/emm.2003.18","volume":"35","author":"C-H Cho","year":"2003","unstructured":"Cho C-H, Lee S-Y, Shin H-S, Philipson KD, Lee CO. Partial rescue of the Na+-Ca2+ exchanger (NCX1) knock-out mouse by transgenic expression of NCX1. Exp Mol Med. 2003;35:125\u201335.","journal-title":"Exp Mol Med"},{"key":"4605_CR41","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1096\/fj.00-0696fje","volume":"15","author":"SV Koushik","year":"2001","unstructured":"Koushik SV, Wang J, Rogers R, Moskophidis D, Lambert NA, Creazzo TL, et al. Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal myofibrillar organization. FASEB J. 2001;15:1209\u201311.","journal-title":"FASEB J"},{"key":"4605_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nprot.2011.435","volume":"7","author":"M Baker","year":"2011","unstructured":"Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D\u2019Amico G, et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc. 2011;7:89\u2013104.","journal-title":"Nat Protoc"},{"key":"4605_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1387\/ijdb.103222rn","volume":"55","author":"RF Nicosia","year":"2011","unstructured":"Nicosia RF, Zorzi P, Ligresti G, Morishita A, Aplin AC. Paracrine regulation of angiogenesis by different cell types in the aorta ring model. Int J Dev Biol. 2011;55:447\u201353.","journal-title":"Int J Dev Biol"},{"key":"4605_CR44","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1111\/j.1582-4934.2009.00891.x","volume":"13","author":"RF Nicosia","year":"2009","unstructured":"Nicosia RF. The aortic ring model of angiogenesis: a quarter century of search and discovery. J Cell Mol Med. 2009;13:4113\u201336.","journal-title":"J Cell Mol Med"},{"key":"4605_CR45","first-page":"4105","volume":"66","author":"SB Weisser","year":"2012","unstructured":"Weisser SB, van Rooijen N, Sly LM. Depletion and reconstitution of macrophages in mice. J Vis Exp. 2012;66:4105.","journal-title":"J Vis Exp"},{"key":"4605_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep22143","volume":"6","author":"Z Li","year":"2016","unstructured":"Li Z, Xu X, Feng X, Murphy PM. The macrophage-depleting agent clodronate promotes durable hematopoietic chimerism and donor-specific skin allograft tolerance in mice. Sci Rep. 2016;6:22143.","journal-title":"Sci Rep"},{"key":"4605_CR47","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1096\/fj.201800331R","volume":"32","author":"S Ghavampour","year":"2018","unstructured":"Ghavampour S, Kleefeldt F, B\u00f6mmel H, Volland J, Paus A, Horst A, et al. Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. FASEB J. 2018;32:5612\u201325.","journal-title":"FASEB J"},{"key":"4605_CR48","doi-asserted-by":"publisher","first-page":"e13025","DOI":"10.1111\/acel.13025","volume":"18","author":"F Kleefeldt","year":"2019","unstructured":"Kleefeldt F, B\u00f6mmel H, Broede B, Thomsen M, Pfeiffer V, W\u00f6rsd\u00f6rfer P, et al. Aging-related carcinoembryonic antigen-related cell adhesion molecule 1 signaling promotes vascular dysfunction. Aging Cell. 2019;18:e13025.","journal-title":"Aging Cell"},{"key":"4605_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00418-017-1562-8","volume":"148","author":"H B\u00f6mmel","year":"2017","unstructured":"B\u00f6mmel H, Kleefeldt F, Zernecke A, Ghavampour S, Wagner N, Kuerten S, et al. Visualization of endothelial barrier damage prior to formation of atherosclerotic plaques. Histochem Cell Biol. 2017;148:117\u201327.","journal-title":"Histochem Cell Biol"},{"key":"4605_CR50","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/eji.1830111013","volume":"11","author":"JM Austyn","year":"1981","unstructured":"Austyn JM, Gordon S. F4\/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981;11:805\u201315.","journal-title":"Eur J Immunol"},{"key":"4605_CR51","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1084\/jem.20042307","volume":"201","author":"H-H Lin","year":"2005","unstructured":"Lin H-H, Faunce DE, Stacey M, Terajewicz A, Nakamura T, Zhang-Hoover J, et al. The macrophage F4\/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med. 2005;201:1615\u201325.","journal-title":"J Exp Med"},{"key":"4605_CR52","doi-asserted-by":"crossref","unstructured":"Lhot\u00e1k \u0160, Gyulay G, Cutz J-C, Al-Hashimi A, Trigatti BL, Richards CD, et al. Characterization of proliferating lesion-resident cells during all stages of atherosclerotic growth. J Am Heart Assoc. 2016;5:e003945.","DOI":"10.1161\/JAHA.116.003945"},{"key":"4605_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer. 2006;6:99\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"4605_CR54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF02303785","volume":"5","author":"JH Harmey","year":"1998","unstructured":"Harmey JH, Dimitriadis E, Kay E, Redmond HP, Bouchier-Hayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol. 1998;5:271\u20138.","journal-title":"Ann Surg Oncol"},{"key":"4605_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2008.08.004","volume":"204","author":"M Riazy","year":"2009","unstructured":"Riazy M, Chen JH, Steinbrecher UP. VEGF secretion by macrophages is stimulated by lipid and protein components of OxLDL via PI3-kinase and PKCzeta activation and is independent of OxLDL uptake. Atherosclerosis. 2009;204:47\u201354.","journal-title":"Atherosclerosis"},{"key":"4605_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341\u201355.","journal-title":"Cell"},{"key":"4605_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41:21\u201335.","journal-title":"Immunity"},{"key":"4605_CR58","doi-asserted-by":"publisher","unstructured":"Weiskopf K, Schnorr PJ, Pang WW, Chao MP, Chhabra A, Seita J, et al. Myeloid cell origins, differentiation, and clinical implications. Microbiol Spectr. 2016;4. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0031-2016.","DOI":"10.1128\/microbiolspec.MCHD-0031-2016"},{"key":"4605_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2011.04.021","volume":"9","author":"SW Boyer","year":"2011","unstructured":"Boyer SW, Schroeder AV, Smith-Berdan S, Forsberg EC. All hematopoietic cells develop from hematopoietic stem cells through Flk2\/Flt3-positive progenitor cells. Cell Stem Cell. 2011;9:64\u201373.","journal-title":"Cell Stem Cell"},{"key":"4605_CR60","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4161\/cc.21279","volume":"11","author":"SW Boyer","year":"2012","unstructured":"Boyer SW, Beaudin AE, Forsberg EC. Mapping differentiation pathways from hematopoietic stem cells using Flk2\/Flt3 lineage tracing. Cell Cycle. 2012;11:3180\u20138.","journal-title":"Cell Cycle"},{"key":"4605_CR61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature13989","volume":"518","author":"E Gomez Perdiguero","year":"2015","unstructured":"Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518:547\u201351.","journal-title":"Nature"},{"key":"4605_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02492-2","volume":"9","author":"C Stremmel","year":"2018","unstructured":"Stremmel C, Schuchert R, Wagner F, Thaler R, Weinberger T, Pick R, et al. Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. Nat Commun. 2018;9:75.","journal-title":"Nat Commun"},{"key":"4605_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2016.07.017","volume":"171","author":"P W\u00f6rsd\u00f6rfer","year":"2017","unstructured":"W\u00f6rsd\u00f6rfer P, Mekala SR, Bauer J, Edenhofer F, Kuerten S, Erg\u00fcn S. The vascular adventitia: an endogenous, omnipresent source of stem cells in the body. Pharm Ther. 2017;171:13\u201329.","journal-title":"Pharm Ther"},{"key":"4605_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI5928","volume":"103","author":"PJ Newman","year":"1999","unstructured":"Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest. 1999;103:5\u20139.","journal-title":"J Clin Invest"},{"key":"4605_CR65","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.4049\/jimmunol.1400853","volume":"193","author":"RS Lam","year":"2014","unstructured":"Lam RS, O\u2019Brien-Simpson NM, Lenzo JC, Holden JA, Brammar GC, Walsh KA, et al. Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in mice. J Immunol. 2014;193:2349\u201362.","journal-title":"J Immunol"},{"key":"4605_CR66","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/nm.3258","volume":"19","author":"CS Robbins","year":"2013","unstructured":"Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo J-L, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19:1166\u201372.","journal-title":"Nat Med"},{"key":"4605_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/86490","volume":"7","author":"FL Celletti","year":"2001","unstructured":"Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med. 2001;7:425\u20139.","journal-title":"Nat Med"},{"key":"4605_CR68","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/ATVBAHA.107.143743","volume":"27","author":"AD Hauer","year":"2007","unstructured":"Hauer AD, van Puijvelde GHM, Peterse N, de Vos P, van Weel V, van Wanrooij EJA, et al. Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2050\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04605-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:49:05Z","timestamp":1669301345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04605-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":68,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["4605"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04605-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}